E-nergEYEze, a vision-specific eHealth intervention based on cognitive behavioral therapy and self-management to reduce fatigue in adults with visual impairment

Reducing fatigue in visually impaired adults with E-nergEYEze: An RCT to assess the cost-effectiveness of a blended vision-specific E-health based cognitive behavioral & self-management intervention’

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28085

Enrollment

172

Registered

2019-05-28

Start date

2020-10-06

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People with a visual impairment and in the experience of severe fatigue Fatigue, Visual impairment, Cognitive behavioral therapy, Self-management, eHealth, Randomized controlled trial

Interventions

&nbsp

De blauwdruk van E-nergEYEze bevat een introductie module plus acht inhoudelijke modules: (a) inzicht in visusgerelateerde vermoeidheid

(b) helpend denken

(d) contact met anderen en sociale steun

(e) stress en ontspanning

(f) optioneel: slaapproblemen en een vast slaap-waakritme

(g) optioneel: optimaliseren werkprestatie

(h) de toekomst tegemoet en realiseren van persoonlijke doelen. E-nergEYEze wordt ondersteund door maatschappelijk werkers via een face-to-face startsessie van één uur, digitaal (ongeveer 3 uur) en t

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Visually impaired (according to WHO criteria and guidelines of the low vision rehabilitation centers) adult outpatients (18+) from Dutch low vision rehabilitation organisations (i.e. Royal Dutch Visio and Bartiméus) who experience severe fatigue (CIS-score>35), have internet-access at home and are able to speak the Dutch language adequately, will be eligible to participate.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: severe cognitive limitations assessed with the 6-item screener (short validated Mini Mental State Examination with a score <3), or currently receiving treatment or having received treatment in the last 12 months for another comorbid disease that clearly is the main cause of fatigue (i.e. multiple sclerosis (MS), cancer, psychiatric disorder).

Design outcomes

Primary

Measure	Time frame
Fatigue severity will be measured with the Fatigue Severity (FS) subscale of the Checklist Individual Strenghts (CIS)	—

Secondary

Measure	Time frame
Adaptation to vision loss, symptoms of depression, anxiety, vision-related quality of life, work functioning and work participation, need for recovery, sleep disorder, health care utilisation, medication use, absenteeism and presenteeism from paid and unpaid work, health-related quality of life.	—

Contacts

Public ContactManon Veldman

Amsterdam University Medical Centre

m.veldman@amsterdamumc.nl020-4444795

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)